(Q33813127)

29 July 2017

1 reference

title

Current medical treatment for tuberculosis (English)

1 reference

29 July 2017

0 references

Edward D Chan

1

1 reference

29 July 2017

Michael D Iseman

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

29 July 2017

1 reference

29 July 2017

volume

325

1 reference

29 July 2017

issue

7375

1 reference

29 July 2017

page(s)

1282-1286

1 reference

Tuberculosis therapy: past, present and future.

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

HIV-1/AIDS and the control of other infectious diseases in Africa

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Issues in the treatment of Mycobacterium tuberculosis in patients with human immunodeficiency virus infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Short-term incarceration for the management of noncompliance with tuberculosis treatment

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Relapse of tuberculosis after treatment in human immunodeficiency virus-infected patients

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Low antituberculosis drug concentrations in patients with AIDS.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Epidemiology of tuberculosis in the United States, 1985 through 1992.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Predictors of short-term prognosis in patients with pulmonary tuberculosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Modeling the epidemiology and economics of directly observed therapy in Baltimore.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Compliance and supervision of chemotherapy of tuberculosis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124748

Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis

30 October 2018

1 reference

12 December 2020

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis

1 reference

12 December 2020

Combined effect of pyrazinamide and ofloxacin within the human macrophage

1 reference

12 December 2020

Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin

1 reference

12 December 2020

Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group

1 reference

12 December 2020

Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors

1 reference

12 December 2020

Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 months

1 reference

12 December 2020

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis

1 reference

12 December 2020

Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 month

1 reference

12 December 2020

Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance

1 reference

12 December 2020

Beyond four drugs. Public health policy and the treatment of the individual patient with tuberculosis

1 reference

12 December 2020

10.1136/BMJ.325.7375.1282

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l53kx44eunhvbp5x74khxzw3xi

30 July 2022

release_l53kx44eunhvbp5x74khxzw3xi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l53kx44eunhvbp5x74khxzw3xi

30 July 2022

https://api.fatcat.wiki/v0/release/l53kx44eunhvbp5x74khxzw3xi

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/l53kx44eunhvbp5x74khxzw3xi

1 reference

30 July 2022